Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Eugenia Quirós-Roldán, Giorgio Biasiotto, Paola Magro, et al.
Pharmacological Research (2020) Vol. 158, pp. 104904-104904
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 43, pp. 26955-26965
Open Access | Times Cited: 264
Ultra-fast proteomics with Scanning SWATH
Christoph B. Messner, Vadim Demichev, Nic Bloomfield, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 7, pp. 846-854
Open Access | Times Cited: 234
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2
E. Barberis, Sara Timo, Elia Amede, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8623-8623
Open Access | Times Cited: 214
Antivirals for COVID-19: A critical review
Andri Frediansyah, Ruchi Tiwari, Khan Sharun, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 90-98
Open Access | Times Cited: 171
Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus
Katarzyna Chojnacka, Anna Witek‐Krowiak, Dawid Skrzypczak, et al.
Journal of Functional Foods (2020) Vol. 73, pp. 104146-104146
Open Access | Times Cited: 165
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Giuseppe Magro
Virus Research (2020) Vol. 286, pp. 198070-198070
Open Access | Times Cited: 130
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
European Journal of Internal Medicine (2020) Vol. 82, pp. 38-47
Open Access | Times Cited: 110
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Amin Gasmi, Massimiliano Peana, Sàdaf Noor, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 4, pp. 1333-1343
Open Access | Times Cited: 84
COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
Shuoqi Zhang, Jinming Zhang, Chunxu Wang, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 3
Open Access | Times Cited: 77
Antiviral performance of graphene-based materials with emphasis on COVID-19: A review
Tahereh Seifi, Ali Reza Kamali
Medicine in Drug Discovery (2021) Vol. 11, pp. 100099-100099
Open Access | Times Cited: 68
Adenosine triphosphate energy‐independently controls protein homeostasis with unique structure and diverse mechanisms
Jianxing Song
Protein Science (2021) Vol. 30, Iss. 7, pp. 1277-1293
Open Access | Times Cited: 62
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Pengxuan Ren, Weijuan Shang, Wanchao Yin, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 2, pp. 483-493
Open Access | Times Cited: 60
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 43
COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
Yasar Sattar, Waqas Ullah, Hiba Rauf, et al.
IJC Heart & Vasculature (2020) Vol. 29, pp. 100589-100589
Open Access | Times Cited: 66
CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury
Mingxing Sui, Da Xu, Wen‐Yu Zhao, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 13, pp. 6203-6216
Open Access | Times Cited: 47
The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants
Khushbu Kumari, Aditya Nandi, Adrija Sinha, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 4, pp. 575-587
Open Access | Times Cited: 17
Optimization of photocatalytic parameters for the photodegradation of hydroxychloroquine sulfate using the Ag/Cu-TNT nanocomposite
Emanuel da Cruz Lima, Francisco Xavier Nobre, Gabriel e Silva Sales, et al.
Journal of Water Process Engineering (2025) Vol. 71, pp. 107205-107205
Closed Access
Impact of Cathepsin L Inhibition in SARS-CoV-2 Infection and Potential Therapeutic Interventions
Muteeba Azhar, Asma Irshad, Ansar Zubair, et al.
BioScientific Review (2025) Vol. 6, Iss. 4, pp. 100-115
Open Access
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Wei‐Yi Ong, Mei‐Lin Go, De Yun Wang, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 106-117
Open Access | Times Cited: 45
A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19
Mohammad Taheri‬, Ali Bahrami, Parisa Habibi, et al.
Biological Trace Element Research (2020) Vol. 199, Iss. 7, pp. 2475-2481
Open Access | Times Cited: 44
Cancer therapy and treatments during COVID-19 era
Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2020) Vol. 77, pp. 100739-100739
Open Access | Times Cited: 43
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
Yi Zhang, Liang Tang
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 49-59
Closed Access | Times Cited: 42
Review of registered clinical trials for the treatment of COVID‐19
Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri‐Asl, et al.
Drug Development Research (2020) Vol. 82, Iss. 4, pp. 474-493
Open Access | Times Cited: 40
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
Isabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 454-454
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top